Clinical Trial Update: A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST) [Phase 2]

View source ↗

Summary

This document announces a Phase 2 clinical trial evaluating ASTX727 in malignant peripheral nerve sheath tumors (MPNST), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peripheral Nerve Sheath Tumor

Drugs mentioned

• ASTX727 (cedazuridine/decitabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Peripheral Nerve Sheath Tumors (MPNST) | Phase 2 | Status: RECRUITING